Promising cancer drug aces human clinical trials
• https://newatlas.com, Michael IrvingA new cancer drug known as BLU-667 has moved through phase I human trials, and the results are promising.
A new cancer drug known as BLU-667 has moved through phase I human trials, and the results are promising.